what class of drug is tirzepatide A 72-week trial compared the two leading GLP-1 Tirzepatide (Mounjaro) In Sherman Oaks

Patients usually begin to lose 8-12 pounds per month

They can reduce inflammation and impact the cardiovascular system improving indicators such as: PFR (indicator of diastolic function) and LVEF (an indicator of left ventricular systolic dysfunction) [19]

Patients should receive clear written and verbal information about: Expected side effects of each medication Warning signs requiring immediate medical attention (severe abdominal pain, persistent vomiting, signs of pancreatitis, mood changes, suicidal thoughts) The importance of adherence to prescribed doses Lifestyle modifications to support treatment goals Multidisciplinary coordination may be beneficial, particularly when care involves both smoking cessation services and weight management clinics

Track and adjust

But it does not match the numbers that retatrutide puts up as a monotherapy